CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer
CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer
Active, not recruiting · NCT04062708 · Registry updated 2026-09-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 2 | 2026-09-23 | NCT04062708 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Alliance Foundation Trials, LLC. | 12 |
| AstraZeneca | 806 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Baptist Cancer Center | Memphis | United States | 22 |
| Brigham and Women's Hospital | Boston | United States | 511 |
| Lowell General Hospital | Lowell | United States | 47 |
| Massachusetts General Hospital | Boston | United States | 1015 |
| Northwestern University | Chicago | United States | 727 |
| SUNY Upstate Medical University | Syracuse | United States | 68 |
| University of Chicago Medical Center | Chicago | United States | 152 |
| University of Texas MD Anderson Cancer Center | Houston | United States | 192 |
| University of Virginia Health System | Charlottesville | United States | 57 |